• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑钠肽水平和最大摄氧量对未来心力衰竭事件的影响:窦性心律与心房颤动之间的比较。

Impact of BNP level and peak VO on future heart failure events: comparison between sinus rhythm and atrial fibrillation.

作者信息

Kato Yuko, Suzuki Shinya, Uejima Tokuhisa, Semba Hiroaki, Kano Hiroto, Matsuno Shunsuke, Takai Hideaki, Otsuka Takayuki, Oikawa Yuji, Nagashima Kazuyuki, Kirigaya Hajime, Sagara Koichi, Kunihara Takashi, Yajima Junji, Sawada Hitoshi, Aizawa Tadanori, Yamashita Takeshi

机构信息

Department of Cardiovascular Medicine, The Cardiovascular Institute, Nishiazabu 3-2-19, Minato-ku, Tokyo, 106-0031, Japan.

Department of Cardiovascular Surgery, The Cardiovascular Institute, Tokyo, Japan.

出版信息

Heart Vessels. 2017 Apr;32(4):428-435. doi: 10.1007/s00380-016-0887-x. Epub 2016 Aug 22.

DOI:10.1007/s00380-016-0887-x
PMID:27550341
Abstract

This study aimed to examine the discrete impacts of peak oxygen consumption (VO) and brain natriuretic peptide (BNP) levels on future heart failure (HF) events in sinus rhythm (SR) and atrial fibrillation (AF). A total of 1447 patients who underwent symptom-limited cardiopulmonary exercise testing and whose BNP values were determined simultaneously were analysed (SR, N = 1151 and AF, N = 296). HF events were defined as HF hospitalization or HF death. Over a mean follow-up period of 1472 days, 140 HF events were observed. A high BNP value (dichotomized by median value) was independently associated with HF events in SR (HR 8.08; 95 % CI 4.02-16.26; p < 0.0001), but not in AF patients (HR 1.97; 95 % CI 0.91-4.28; p = 0.087) with a significant interaction between the rhythms. By contrast, low-peak VO was independently associated with HF events in both rhythms (AF; HR 5.81; 95 % CI 1.75-19.30; p = 0.004, SR; HR 2.04; 95 % CI 1.19-3.49; p = 0.009), with a marginal interaction between them. In bivariate Cox models, low-peak VO had much stronger predictive power for HF events than high-BNP in AF, whereas high-BNP was more powerful than low-peak VO in SR. The prognostic value of BNP and peak VO for future HF events seemed to be different between SR and AF.

摘要

本研究旨在探讨峰值耗氧量(VO)和脑钠肽(BNP)水平对窦性心律(SR)和心房颤动(AF)患者未来发生心力衰竭(HF)事件的独立影响。对1447例接受症状限制性心肺运动试验且同时测定BNP值的患者进行了分析(SR组1151例,AF组296例)。HF事件定义为HF住院或HF死亡。在平均1472天的随访期内,观察到140例HF事件。高BNP值(以中位数二分法划分)与SR患者的HF事件独立相关(HR 8.08;95%CI 4.02-16.26;p<0.0001),但在AF患者中无相关性(HR 1.97;95%CI 0.91-4.28;p=0.087),且两种心律之间存在显著交互作用。相比之下,低峰值VO与两种心律的HF事件均独立相关(AF组:HR 5.81;95%CI 1.75-19.30;p=0.004,SR组:HR 2.04;95%CI 1.19-3.49;p=0.009),两者之间存在微弱交互作用。在双变量Cox模型中,低峰值VO对AF患者HF事件的预测能力远强于高BNP,而在SR患者中高BNP比低峰值VO更具预测力。BNP和峰值VO对未来HF事件的预后价值在SR和AF之间似乎有所不同。

相似文献

1
Impact of BNP level and peak VO on future heart failure events: comparison between sinus rhythm and atrial fibrillation.脑钠肽水平和最大摄氧量对未来心力衰竭事件的影响:窦性心律与心房颤动之间的比较。
Heart Vessels. 2017 Apr;32(4):428-435. doi: 10.1007/s00380-016-0887-x. Epub 2016 Aug 22.
2
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.射血分数保留的心力衰竭中的心房颤动:与运动能力、左心室充盈压、利钠肽和左心房容积的关系。
JACC Heart Fail. 2017 Feb;5(2):92-98. doi: 10.1016/j.jchf.2016.10.005. Epub 2016 Dec 21.
3
Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation.基于复杂性心房颤动的心力衰竭管理中可区分的血浆B型利钠肽最佳水平
Int Heart J. 2005 May;46(3):453-64. doi: 10.1536/ihj.46.453.
4
Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.左心室射血分数降低和保留的心力衰竭伴心房颤动患者的临床和预后影响。
Eur J Heart Fail. 2011 Oct;13(10):1111-20. doi: 10.1093/eurjhf/hfr066. Epub 2011 Jun 3.
5
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation.收缩期心力衰竭合并心房颤动患者无氧阈时测得的摄氧量的欺骗性意义。
Eur J Prev Cardiol. 2015 Aug;22(8):1046-55. doi: 10.1177/2047487314551546. Epub 2014 Sep 26.
6
Prognostic value of cardiopulmonary exercise testing in cardiac patients with atrial fibrillation.心肺运动试验对合并心房颤动的心脏病患者的预后价值
Int Heart J. 2012;53(2):102-7. doi: 10.1536/ihj.53.102.
7
Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.运动试验对心房颤动患者利钠肽分泌的影响。
Kardiol Pol. 2009 Mar;67(3):254-61.
8
A high BNP level predicts an improvement in exercise tolerance after a successful catheter ablation of persistent atrial fibrillation.高 BNP 水平预示着持续性心房颤动经导管消融成功后运动耐量的改善。
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2283-2290. doi: 10.1111/jce.14149. Epub 2019 Sep 8.
9
Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.B型利钠肽与峰值耗氧量联合应用可改善慢性心力衰竭门诊患者的风险分层。
Am Heart J. 2003 Oct;146(4):729-35. doi: 10.1016/S0002-8703(03)00365-X.
10
Prognostic value of the heart rate profile during exercise in patients with atrial fibrillation.运动时心房颤动患者心率曲线的预后价值。
Eur J Prev Cardiol. 2018 Oct;25(15):1634-1641. doi: 10.1177/2047487318797398. Epub 2018 Aug 30.

引用本文的文献

1
Effect of exercise therapy on established and emerging circulating biomarkers in patients with heart failure: a systematic review and meta-analysis.运动疗法对心力衰竭患者已有的和新出现的循环生物标志物的影响:一项系统评价和荟萃分析。
Open Heart. 2018 Jul 11;5(2):e000819. doi: 10.1136/openhrt-2018-000819. eCollection 2018.
2
Predictors of improvements in exercise capacity during cardiac rehabilitation in the recovery phase after coronary artery bypass graft surgery versus acute myocardial infarction.冠状动脉搭桥手术后与急性心肌梗死后恢复阶段心脏康复期间运动能力改善的预测因素。
Heart Vessels. 2018 Apr;33(4):358-366. doi: 10.1007/s00380-017-1076-2. Epub 2017 Nov 8.
3

本文引用的文献

1
Prognostic significance of exercise capacity and resting heart rate: Comparison between atrial fibrillation and sinus rhythm.运动能力和静息心率的预后意义:心房颤动与窦性心律的比较
Int J Cardiol. 2016 Jan 15;203:561-3. doi: 10.1016/j.ijcard.2015.10.227. Epub 2015 Oct 30.
2
NT-proBNP values in elderly heart failure patients with atrial fibrillation and diabetes.老年房颤合并糖尿病心力衰竭患者的N末端B型利钠肽原(NT-proBNP)值
J Diabetes Complications. 2015 Nov-Dec;29(8):1119-23. doi: 10.1016/j.jdiacomp.2015.08.013. Epub 2015 Aug 20.
3
Evidence based application of BNP/NT-proBNP testing in heart failure.
Prognostic value of selected echocardiographic, impedance cardiographic, and hemodynamic parameters determined during right heart catheterization in patients qualified for heart transplantation.
在符合心脏移植条件的患者右心导管检查期间测定的选定超声心动图、阻抗心动图和血流动力学参数的预后价值。
Heart Vessels. 2018 Feb;33(2):180-190. doi: 10.1007/s00380-017-1044-x. Epub 2017 Sep 22.
4
Evaluation of end-tidal CO pressure at the anaerobic threshold for detecting and assessing pulmonary hypertension.评估呼气末二氧化碳分压在无氧阈时对检测和评估肺动脉高压的作用。
Heart Vessels. 2017 Nov;32(11):1350-1357. doi: 10.1007/s00380-017-0999-y. Epub 2017 May 30.
BNP/NT-proBNP检测在心力衰竭中的循证应用
Clin Biochem. 2015 Mar;48(4-5):236-46. doi: 10.1016/j.clinbiochem.2014.11.002. Epub 2014 Nov 8.
4
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation.收缩期心力衰竭合并心房颤动患者无氧阈时测得的摄氧量的欺骗性意义。
Eur J Prev Cardiol. 2015 Aug;22(8):1046-55. doi: 10.1177/2047487314551546. Epub 2014 Sep 26.
5
Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).心房颤动使呼吸困难患者中心脏利钠肽的诊断性能受损:来自 BACH 研究(急性心力衰竭中的生物标志物)的结果。
JACC Heart Fail. 2013 Jun;1(3):192-9. doi: 10.1016/j.jchf.2013.02.004. Epub 2013 Jun 3.
6
Plasma B-type natriuretic peptide as a predictor of cardiovascular events in subjects with atrial fibrillation: a community-based study.血浆 B 型利钠肽作为房颤患者心血管事件预测因子的一项社区研究。
PLoS One. 2013 Dec 2;8(12):e81243. doi: 10.1371/journal.pone.0081243. eCollection 2013.
7
Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study.房颤患者的死亡原因和影响因素:来自随机长期抗凝治疗研究的竞争风险分析。
Circulation. 2013 Nov 12;128(20):2192-201. doi: 10.1161/CIRCULATIONAHA.112.000491. Epub 2013 Sep 9.
8
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).N 末端 B 型利钠肽前体在心房颤动患者风险评估中的应用:来自 ARISTOTLE 试验(阿哌沙班预防心房颤动患者卒中)的观察。
J Am Coll Cardiol. 2013 Jun 4;61(22):2274-84. doi: 10.1016/j.jacc.2012.11.082. Epub 2013 Apr 3.
9
A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation.一种用于评估日本心房颤动患者心力衰竭事件风险的新评分系统。
Am J Cardiol. 2012 Sep 1;110(5):678-82. doi: 10.1016/j.amjcard.2012.04.049. Epub 2012 May 22.
10
Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.心脏生物标志物与房颤患者的中风和死亡风险增加相关:随机长期抗凝治疗(RE-LY)子研究。
Circulation. 2012 Apr 3;125(13):1605-16. doi: 10.1161/CIRCULATIONAHA.111.038729. Epub 2012 Feb 28.